Olaparib has synergistic effects with DNA damaging agents in pancreatic ductal adenocarcinoma
{{output}}
Background: Pancreatic ductal adenocarcinoma (PDAC) remains among the most lethal malignancies. Poly (ADP-ribose) polymerase (PARP) enzymes have a crucial function in the DNA repair and their inhibition has been recently shown to... ...
